Hyperactivation of mTORC1 drives acquired resistance to the pan -HER tyrosine kinase inhibitor neratinib in HER2-mutant cancersDhivya R. Sudhan,Angel Guerrero-Zotano,Helen Won,Paula Gonzales Ericsson,Qi Liu,Teresa Dugger,James Koch,Alison Schram,Alberto Servetto,Richard Cutler,Alshad Lalani,Richard Bryce,Alan Auerbach,Ariella Hanker,Carlos L. ArteagaCANCER RESEARCH(2019)引用 0|浏览36暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要